Lidakol n-docosanol 10 percent cream: Began enrolling Canadian patients in a 750-patient Phase III trial that is underway in the U.S.

Lidak Pharmaceuticals (LDAKA), La Jolla, Calif. Product: Lidakol n-docosanol 10 percent cream Indication: Herpes labialis (cold sores) Status: Began enrolling Canadian patients in a 750-patient Phase ...